Associated Papers
A heterozygous nonsense mutation in the FGB gene (c.1299G > A) causes congenital fibrinogen disorder across four consecutive generations.
Chen W et al.
Thrombosis Journal, 2025
Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders.
Casini A et al.
Seminars in Thrombosis and Hemostasis, 2025
Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma.
Dong W et al.
World Journal of Surgical Oncology, 2022
36471393 (PubMed )
Supplement: 12957_2022_2849_MOESM4_ESM.xlsx › enrichment.PMID
Mutations Accounting for Congenital Fibrinogen Disorders: An Update.
Richard M et al.
Seminars in Thrombosis and Hemostasis, 2022
Heterogeneity of Genotype-Phenotype in Congenital Hypofibrinogenemia-A Review of Case Reports Associated with Bleeding and Thrombosis.
Brunclikova M et al.
Journal of Clinical Medicine, 2022
Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.
Gindele R et al.
Life (basel, Switzerland), 2021
A Novel Nonsense Mutation in FGB (c.1421G>A; p.Trp474Ter) in the Beta Chain of Fibrinogen Causing Hypofibrinogenemia with Bleeding Phenotype.
Simurda T et al.
Biomedicines, 2020
Select a paper to view details